| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.007 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.007 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.086 | 0.008 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.097 | 0.008 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.09 | 0.008 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.091 | 0.008 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.009 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.009 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.009 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |